ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea · Delayed Price · Currency is KRW 3,190.00
-200.00 (-5.90%)
At close: Jun 26, 2026
ImmuneOncia Therapeutics Market Cap
ImmuneOncia Therapeutics has a market cap or net worth of 334.06 billion as of June 29, 2026. Its market cap has decreased by -29.71% in one year.
Market Cap
334.06B
Enterprise Value
315.12B
Revenue
59.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
3,190.00
Market Cap Chart
Since May 19, 2025, ImmuneOncia Therapeutics's market cap has decreased from 547.53B to 334.06B, a decrease of -38.99%. That is a compound annual growth rate of -36.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 291.16B | -69.85% |
| Dec 30, 2025 | 965.63B | 76.36% |
| May 19, 2025 | 547.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 595.63B |
| Samyang Biopharm | 317.14B |
| HEM Pharma | 299.61B |
| NOVAREX | 199.55B |
| CellBion | 192.29B |
| DAE HWA Pharmaceutical | 153.62B |
| Vivozon Pharmaceutical | 149.81B |
| High Tech Pharm | 135.15B |